Correlation Between Mink Therapeutics and Kezar Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and Kezar Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and Kezar Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and Kezar Life Sciences, you can compare the effects of market volatilities on Mink Therapeutics and Kezar Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of Kezar Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and Kezar Life.

Diversification Opportunities for Mink Therapeutics and Kezar Life

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Mink and Kezar is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and Kezar Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kezar Life Sciences and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with Kezar Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kezar Life Sciences has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and Kezar Life go up and down completely randomly.

Pair Corralation between Mink Therapeutics and Kezar Life

Given the investment horizon of 90 days Mink Therapeutics is expected to under-perform the Kezar Life. But the stock apears to be less risky and, when comparing its historical volatility, Mink Therapeutics is 1.53 times less risky than Kezar Life. The stock trades about -0.06 of its potential returns per unit of risk. The Kezar Life Sciences is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  709.00  in Kezar Life Sciences on September 1, 2024 and sell it today you would earn a total of  38.00  from holding Kezar Life Sciences or generate 5.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Mink Therapeutics  vs.  Kezar Life Sciences

 Performance 
       Timeline  
Mink Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mink Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's forward-looking signals remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Kezar Life Sciences 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Kezar Life Sciences are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Kezar Life reported solid returns over the last few months and may actually be approaching a breakup point.

Mink Therapeutics and Kezar Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mink Therapeutics and Kezar Life

The main advantage of trading using opposite Mink Therapeutics and Kezar Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, Kezar Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kezar Life will offset losses from the drop in Kezar Life's long position.
The idea behind Mink Therapeutics and Kezar Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk